Vista Pharmaceuticals Ltd Share Price

8.10

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 04-Feb-2020 - -
VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2020 ,inter alia, to consider and approve With reference to the subject cited, the meeting of the Board of Directors of the Company M/s. Vista Pharmaceuticals Limited will be held on Thursday, 13th day of February, 2020 at 04.00 P.M at the Corporate office of the Company Situated at 7-1-212/A/70, 1st Floor, Plot No. 85, Shivbagh, Ameerpet, Hyderabad- 500016, Telangana inter-alai to discuss the following: 1.To consider, approve and take on record the un-audited Financial Results of the company for the quarter ended 31st December, 2019. 2.To consider and take note of Limited Review Report for the quarter ended 31st December, 2019. 3.To take note and accept resignation of Mr. Venkata Chalapathi Rao Naraparaju (DIN: 03270178) Whole time Director of the Company. 4.Any other items with the permission of chairman. This is for the kind information and records of the Exchange.
Board Meeting - 29-Oct-2019 - -
VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2019 ,inter alia, to consider and approve With reference to the subject cited, the meeting of the Board of Directors of the Company M/s. Vista Pharmaceuticals Limited will be held on Thursday, 07th day of November, 2019 at 03.00 P.M at the Corporate office of the Company Situated at 7-1-212/A/70, 1st Floor, Plot No. 85, Shivbagh, Ameerpet, Hyderabad- 500016, Telangana inter-alai to discuss the following: 1. To consider, approve and take on record the un-audited Financial Results of the company for the quarter and half year ended 30th September, 2019. 2. To consider and take note of Limited Review Report for the quarter and half year ended 30th September, 2019. 3. Any other items. This is for the kind information and records of the Exchange.
Board Meeting - 30-Sep-2019 - -
Outcome of Board Meeting held on 30.09.2019.
Board Meeting - 07-Aug-2019 - -
VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2019 ,inter alia, to consider and approve With reference to the subject cited, the meeting of the Board of Directors of the Company M/s. Vista Pharmaceuticals Limited will be held on Wednesday, 14.08.2019 at 03.00 P.M at the Corporate office of the Company Situated at 7-1-212/A/70, 1st Floor, Plot No. 85, Shivbagh, Ameerpet, Hyderabad- 500016, Telangana inter-alai to discuss the following: 1. To consider, approve and take on record the un-audited Financial Results of the company for the quarter ended 30th June, 2019. 2. To consider and take note of Limited Review Report for the quarter ended 30th June, 2019. and other items With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Wednesday, 14th August, 2019 at 3:00 PM, at the corporate office of the Company inter-alia considered and approved the following: 1. Un-Audited Financial Results for the quarter ended 30th June, 2019. 2. Limited Review Report for the quarter ended 30th June, 2019. 3. Draft Board of Directors Report on the companys activities for the financial year ended March 31st, 2019. 4. To convene the 28th Annual General Meeting of the company for the financial year 2018-19 to be held on Thursday, 19th August, 2019 at the Registered office of the Company. 5. Draft Notice for the 28th Annual General Meeting of the Members of the Company. 6. Draft Secretarial Audit Report for the financial year ended 31st March, 2019. 7. Certificate from Managing Director & Chief Financial Officer of the Company for the financial year ended 31st March, 2019. and others With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its meeting held on Wednesday, 14th August, 2019 at 3.00 P.M. at the Corporate office of the Company, interalia, considered and approved the unaudited Financial Results for the quarter ended 30th June, 2019. Copy of un-audited Financial Results for the quarter ended 30th June, 2019 and Limited review Report is enclosed herewith. Kindly take the same on record and acknowledge the receipt of the same. With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Wednesday, 14th August, 2019 at 3:00 PM, at the corporate office of the Company inter-alia considered and approved the following: 1. Un-Audited Financial Results for the quarter ended 30th June, 2019. 2. Limited Review Report for the quarter ended 30th June, 2019. 3. Draft Board of Directors Report on the companys activities for the financial year ended March 31st, 2019. 4. To convene the 28th Annual General Meeting of the company for the financial year 2018-19 to be held on Thursday, 19th September, 2019 at the Registered office of the Company. 5. Draft Notice for the 28th Annual General Meeting of the Members of the Company. 6. Draft Secretarial Audit Report for the financial year ended 31st March, 2019. 7. Certificate from Managing Director & Chief Financial Officer of the Company for the financial year ended 31st March, 2019. and others (As Per BSE Announcement Dated 14.08.2019)
Board Meeting - 22-May-2019 - -
VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve With reference to the subject cited, the meeting of the Board of Directors of the Company M/s. Vista Pharmaceuticals Limited will be held on Thursday, 30.05.2019 at 11.30 A.M at the Corporate office of the Company Situated at 7-1-212/A/70, 1st Floor, Plot No. 85, Shivbagh, Ameerpet, Hyderabad- 500016, inter-alai to discuss the following: 1. To consider, approve and take on record the audited Financial Results of the company for the quarter and year ended 31st March, 2019. 2. To consider and take note of draft Auditors Report for the quarter and year ended 31st March, 2019. With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Thursday, 30th May, 2019 at 11:30 AM, at the corporate office of the Company inter-alia considered the following: 1. Approval of Audited financial statements of the Company for the quarter and financial year ended 31st March, 2019. 2. Took note of Draft Auditors Report on the financial statements of the Company for the financial year ended 31st March, 2019. 3. Approved the Appointment of a) V. Durga Prasad & Associates, Chartered Accountants as Internal Auditors of the Company for the FY 2019-20. b) M/s. NVSS Suryanarayana Rao, Practicing Company Secretary, as Secretarial Auditor of the Company for the FY 2018-19. 4. Took note that 2,81,855 and 10,00,000 convertible warrants allotted to Mr. Vasant V Alli (promoter) and LRSD Securities Private Limited (non-promoter) respectively, due for conversion into equity shares have not been converted in stipulated time. Hence, upfront money received on warrants is forfeited by the Company. With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its meeting held on Thursday, 30th May, 2019 at 11.30 A.M. at the Corporate office of the Company, interalia, considered and approved the audited Financial Results for the quarter and year ended 31st March, 2019. Copy of audited Financial Results for the quarter and year ended 31st March, 2019, along with Statement of Assets and Liabilities and Audit Report is enclosed herewith. Kindly take the same on record and acknowledge the receipt of the same. (As Per BSE Announcement Dated 30.05.2019)
Board Meeting - 16-Mar-2019 - -
With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at their meeting held on Saturday, 16th March, 2019 at 11:00 AM at the Corporate office of the Company, interalia considered and took note of Vacation of office of Ms. Vani Vatti, Director of the Company on incurring the disqualification to act as Directors under Section 164(2) of the Companies Act, 2013.
Open Demat Account